Clinical trial
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving…
NCT00124332 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00124332 |
|---|---|
| Title | STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study) |
| Official title | Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group Trial of Rimonabant 20-mg od, for Inhibition of Atherosclerosis Progression Assessed by IVUS (IntraVascular UltraSounds), in Overweight Patients With Clustering Risk Factors |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Atherosclerosis |
| Intervention type | Drug |
| Interventions | Rimonabant (SR141716), Placebo |
| Enrollment | 839 |
| Start date | Jan 1, 2005 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jul 27, 2005 |
| Last update posted | Apr 20, 2009 |
| Countries | Australia, Belgium, Canada, France, Italy, Netherlands, Poland, Spain, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: